The Global Health Exhibition (GHE) 2025 opened this week in Riyadh, marking a milestone moment for the Kingdom’s healthcare sector. More than $33 billion in new agreements and partnerships were unveiled, underscoring Saudi Arabia’s emergence as one of the world’s most dynamic healthcare investment destinations.
Held under the patronage of the Ministry of Health and aligned with Vision 2030 and the Health Sector Transformation Program, the 8th edition of GHE—organised by Tahaluf—is bringing together leaders from around the world to accelerate healthcare innovation, localisation, and sustainable development.
Transforming Healthcare Infrastructure
The opening day announcements highlighted $8.4 billion in hospital expansion and infrastructure projects, setting a clear direction toward improved access and quality of care.
Key developments include:
- Hayat National Hospitals expanding to 15 facilities with over 4,000 beds through a $1.86 billion investment.
- Akdital Group, Morocco’s largest private healthcare provider, entering the Saudi market with $1.41 billion in projects.
- Mouwasat investing $1.33 billion to expand across Jeddah, Yanbu, Abha, and Khobar.
- Alrajhi Medicine and Burjeel Holdings committing nearly $2 billion combined for new medical centres and projects by 2030. These investments signal strong confidence in Saudi Arabia’s healthcare transformation, particularly in private sector participation and international collaboration.
Life Sciences and Innovation at the Core
The life sciences and pharmaceutical manufacturing sectors are seeing sustained momentum, with more than $625 millioncommitted to localisation, R&D, and vaccine production. Among the highlights:
- BD is investing $266 million in local medical technology manufacturing and training.
- Lifera is partnering with Sanofi, MSD, Pfizer, and Jamjoom Pharma to strengthen domestic vaccine and biopharmaceutical capabilities.
Investment Funds Fueling Future Growth
Over $3.24 billion has been allocated to new venture capital funds and financing instruments, demonstrating the sector’s long-term attractiveness. Notable commitments include:
- Hillhouse investing $1.49 billion in pharmaceutical R&D.
- Al Fozan Holding pledging $675 million for next-generation clinical infrastructure.
- TMV Capital Healthcare and Baraya directing $405 million into rehabilitation and long-term care facilities.
“From Investing in Pain to Investing in Hope”
H.E. Fahad bin Abdulrahman Aljalajel, Minister of Health, highlighted the nation’s shift from treatment-based care to a prevention-first model, noting that Saudi Arabia is nearing its Vision 2030 goal of 79.7 years in life expectancy, up from 74 years in 2016.
“We have moved from treatment after illness to prevention before illness, and from investing in pain to investing in hope,” said the Minister.
The event also featured remarks from HRH Princess Reema bint Bandar Al Saud, Saudi Ambassador to the U.S., who emphasised the importance of international partnerships in achieving global health progress.
A Global Hub for Health Innovation
With participation from global leaders such as GE, Siemens Healthineers, Fujifilm, Johnson & Johnson, GSK, Samsung, and Stryker, alongside Saudi institutions including Health Holding, NUPCO, and Dallah Health, this year’s exhibition marks the most globally connected edition to date.
As the week continues, discussions are turning to digital transformation, smart hospitals, AI in healthcare, and patient-centred innovation.
Gareth Presch, CEO of the World Health Innovation Summit, commented:
“Saudi Arabia’s healthcare investment strategy represents a bold, future-focused approach — aligning prevention, innovation, and sustainability. It’s inspiring to see a national vision being realised through partnerships that prioritise better health and wellbeing for all. This is precisely the kind of systemic collaboration we need to build thriving, healthy communities globally.”